Lightnews — Scholar-powered news

Lumanity @lumanity.bsky.social · 21h

Well said!

Reposted by Lumanity

ISEH - International Society for Experimental Hematology @isehsociety.bsky.social · 3d

There are ✌️ weeks left to register for the FREE 22 October webinar on Responsible AI in Research and Publishing featuringLaura Watts, PhD from @lumanity.bsky.social and @p4sc4l.substack.com from Wiley. Register here 👉 iseh.org/Webinars-Eve...

2 2

Lumanity @lumanity.bsky.social · 1d

In our new podcast episode, Jenny Payne speaks candidly with Ashlee Cramer and Ceinwen Giles about the realities of caregiving, the sacrifices made, and the moments of post-traumatic growth that can emerge from hardship. Join us in recognizing the voices that too often go unheard: buff.ly/6Ca9xNq

1 1 1

Lumanity @lumanity.bsky.social · 1d

Join us on our upcoming webinar "Embedding Patient-Centricity Across Biopharma: From Asset to Enterprise Transformation," to start building a patient-first future for your business. Register now to secure your spot: buff.ly/vfnPED6

Lumanity @lumanity.bsky.social · 2d

We are honored to be among this year’s #MMMAwards finalists!

As we gear up for the biggest event of the year in medical marketing, we extend our congratulations to all the finalists.

We look forward to celebrating the most inspiring and innovative work in our industry tonight.

Lumanity @lumanity.bsky.social · 2d

In the Netherlands, an estimated 1,500–2,000 individuals are living with #SickleCellDisease (SCD), yet there's limited #RealWorldData on the clinical burden, especially regarding recurrent vaso-occlusive crisis. Learn more at buff.ly/5PNBMxr

#SickleCellAwareness #RWE

Lumanity @lumanity.bsky.social · 2d

Meet the Lumanity Team at AMCP Nexus 2025! We’re looking forward to heading to National Harbor, MD for this year’s #AMCPNexus. Our team of experts will be on-site. Want to connect at the conference? Visit our webpage to schedule a meeting with the team: buff.ly/n72xQHh

Lumanity @lumanity.bsky.social · 3d

Jeff Bockman will join investors, VCs and private equity experts at the Global Cancer Research & Innovation Symposium panel; “Global Trends and Reality Checks on the State of Cancer Research.” Learn more: buff.ly/BIlzPED October 21, 2025 | 8:00am – 8:45am | New York, NY #Oncology #GCRIS

Lumanity @lumanity.bsky.social · 3d

#ICYMI: Psychedelic and psychedelic-inspired treatments are shifting from early promise to scalable reality. Our whitepaper distils the critical decisions for leaders in this space: buff.ly/D4dof51

#MentalHealth #Psychedelics #ClinicalDevelopment

Lumanity @lumanity.bsky.social · 3d

No launch succeeds in isolation. Cross-functional coordination is the driving force behind launch success. Our new guide shows how aligning creative, medical, market access, and client teams can transform your launch trajectory. Learn how to synchronize your teams for launch success: buff.ly/mlKdA07

Lumanity @lumanity.bsky.social · 4d

Ed Saltzman is featuring on an insightful #GCRIS panel; “Biotech Investors: How Do We Navigate Choppy Seas” on October 21 from 8:45-9:30am in New York. This session will tackle funding challenges in cancer research amid political and economic uncertainty. Learn more: buff.ly/BIlzPED #Biotech

Lumanity @lumanity.bsky.social · 4d

We're excited to be at Fierce Biotech Week, kicking off this morning! Connect with our on-site staff while at the conference, stop by the Lumanity booth, and don't miss our two insightful panel sessions today. #FierceBiotechWeek #Biotech #PharmaInnovation #BD&L #ClinReg #ClinicalAndRegulatory

Lumanity @lumanity.bsky.social · 4d

Join Laura Watts (Lumanity) and Pascal Hetzscholdt (Wiley) for the ISEH Junior Faculty Committee’s live webinar: “Responsible AI in Research and Publishing: From Best Practice to Practical Application” on October 22 at 9:00am ET. Registration is free for all attendees — sign up now: buff.ly/T7pqALP

Lumanity @lumanity.bsky.social · 4d

We’re excited to share that Jeff Bockman will be moderating the #AVBCCSummit2025 panel “Biotech Investors: Navigating Choppy Seas” on October 24. Join us as we explore the funding challenges in cancer research amid political and economic uncertainty. buff.ly/Wdk102p

Lumanity @lumanity.bsky.social · 5d

We are thrilled to be part of Fierce Biotech Week, kicking off tomorrow! Don’t miss the opportunity to visit our Lumanity team at two insightful panels and our booth.

#FierceBiotechWeek #PharmaInnovation #BDL #ClinReg

Pharma's Partnership Priorities at Fierce Biotech Boston

The State of Drug Development at Fierce Biotech Boston

Lumanity @lumanity.bsky.social · 5d

From rhetoric to reality: is pharma truly integrating the patient voice? Our Expert Patient Council debates the gap between words & action—and how to build real partnerships. Insights here: lumanity.com/perspectives... #PatientEngagement #PatientCentricity

Lumanity @lumanity.bsky.social · 7d

Lumanity can help you make strategic decisions that maximize asset and platform opportunity, mitigate risk, and drive innovation, differentiation, and value.

buff.ly/6ksoUmc

#LifeSciencesConsulting #StrategyConsulting

Lumanity @lumanity.bsky.social · 7d

Lumanity will be attending #AMCPNexus 2025 in National Harbor, MD. Whether you’re interested in collaborating, discussing your next project, or exploring career opportunities with us, we’d love to chat. Visit our event page to see who’s attending and schedule time with our team: buff.ly/n72xQHh

Lumanity @lumanity.bsky.social · 8d

Our recent white paper highlights the role of RWE in JCA guidelines and our advice for companies utilizing RWE for JCA submissions. Read our latest paper for more information at buff.ly/BB9K5nW

#JCA #EUHTA #ATMP #RWE #JCAFramework #HTA #EUHTA

Lumanity @lumanity.bsky.social · 8d

Lumanity will be at the 2025 American College of Rheumatology (ACR) Convergence meeting. We look forward to meeting rheumatology experts and discussing emerging developments in the field! If you would like to meet, email [email protected]. buff.ly/sZc6BK8

#ACR25 #ACRConvergence #Rheumatology

Lumanity @lumanity.bsky.social · 9d

Our new white paper introduces our Value Inflection Point Framework, a practical guide to aligning #strategy, #evidence, #engagement, and #technology at the moments that most influence success. See how to future-proof your next product: buff.ly/Xcs8CMM

#WeAreLumanity

Lumanity @lumanity.bsky.social · 9d

Next week, we will be at the ARM Cell and Gene #MeetingOnTheMesa 2025. We look forward to connecting with our network in Phoenix and gaining valuable industry insights. Schedule a time to meet with us via [email protected] or on PartneringOne: buff.ly/Olg6VgV

Lumanity @lumanity.bsky.social · 10d

Join us tomorrow, "Navigating Regulatory Inspections with Confidence" on October 2 from 11:30am - 12:15pm EDT. Learn how to move from a state of reactive stress to one of "always inspection ready." Register here: buff.ly/7N6zSiS

#RegulatoryAffairs #QualityAssurance

Lumanity @lumanity.bsky.social · 10d

By aligning strategy, evidence generation, stakeholder engagement, and technology at each inflection point, we help biopharma teams accelerate access, strengthen adoption, and deliver better outcomes for patients. Explore how: buff.ly/ncwnSVB

#WeAreLumanity

Lumanity @lumanity.bsky.social · 10d

We’re excited to share a recent co-authored publication in Dermatology and Therapy exploring the burden of pediatric psoriasis. Read the full article: buff.ly/P7Cd84r

#PediatricPsoriasis #HealthEconomics #DermatologyResearch #HEOR